Artificial pancreas will be created by diabetes scientists with insulin pump manufacturer, Animas.
The Juvenile Diabetes Research Foundation (JDRF) chose Johnson & Johnson unit to develop and try the new technologies, namely “pump and control system for type 1 diabetes”.
“This will be a research and development for the first stage towards to create artificial pancreas,” Henry Anhalt, director of medical affairs of Animas said. (Reuters- Maggie Fox)
Animas will work with the foundation to creates a combination of recording devices of glucose, insulin pumps, and some wireless technology software. The new system will facilitate people with diabetes to check their blood sugar level and injecting insulin.
The goal is to create tool that can check the blood sugar level at any time and injecting insulin when needed, without the help of others. This means that the artificial pancreas technology in the future will become one package.
“Here in lies the magical power, when artificial pancreas is able to communicate with each other. Now artificial pancreas is already available but still separated, “said Alan Lewis, chief executive officer and president of the JDRF.
“Animas will provide the equipment while JDRF will be a partner that uses our knowledge and expertise, “said Alan Lewis.
The foundation already spends eight million dollars for the next three years for artificial pancreas project. The goal is to have the first generation technology of artificial pancreas that can be evaluated during the next four years.
Type-1 diabetes is “autoimune” disease, the body’s immune system destroying the pancreas cells that produce insulin so the body is no longer able to dissolve and use the sugar. If not treated, it will damage the blood vessels and nerves, organs, and eventually type 1 diabetes patient will died.
In fact, even treated, the blood vessels and damaged organs are still remain, blindness, kidney failure, and even loss of limbs. In United States (U.S.) only are estimated 3 million people, average children and adolescents was suffer for diabetes type-1.
“This could be a first aid that not only improve glucose control but also lift the entire problem,” said Aaron Kowalsky from JDRF.
Unfortunately the software that regulates insulin pumps and blood sugar are not completely works well. Animas and JDRF will work together to find the best formula for it.
“No single algorithm was consistent with the symptoms of the patient,” said Anhallt, child pancreas organs specialist.
According to Lewis, DexCom Inc which creates glucose control equipment will provide their products to become a part of the artificial pancreas package.
“All parents who have to wake up every night to check their children blood sugar levels will be more relieved that their children are no longer have to going up at night because their blood sugar levels are very low,” Kowalski said, who also suffered from type 1 diabetes.